Beigene Ltd (NASDAQ:BGNE)

187.00
BATS BZX Real-Time Price
As of 10:44am ET
 +5.94 / +3.28%
Today’s Change
118.18
Today|||52-Week Range
426.56
-30.98%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$17.3B

Company Description

BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Cambridge, MA.

Contact Information

BeiGene Ltd.
55 Cambridge Parkway
Cambridge Massachusetts 02142
P:(781) 801-1800
Investor Relations:

Employees

Shareholders

Other institutional32.62%
Mutual fund holders21.13%
Individual stakeholders16.69%

Top Executives

John V. OylerChairman & Chief Executive Officer
Xiao Bin WuPresident & Chief Operating Officer
Julia WangChief Financial & Accounting Officer
Christiane LangerSenior Vice President-Global Medical Affairs
Mark LanasaChief Medical Officer